HIV/AIDS
New findings from the United States, France and United Kingdom in the area of HIV/AIDS detailed
Published in AIDS Weekly, June 5th, 2006
Study 1: HIV-1 Vif recognizes APOBEC3G and APOBEC3F by different mechanisms.
According to recent research from the United States, "APOBEC3G (A3G) and related cytidine deaminases, such as APOBEC3F (A3F), are potent inhibitors of retroviruses. Formation of infectious human immunodeficiency virus type 1 (HTV-1) requires suppression of multiple cytidine deaminases by Vif.
"Whether HIV-1 Vif recognizes various APOBEC3 proteins through a common mechanism is unclear. The domains in Vif that mediate APOBEC3 recognitions are also poorly defined. The...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of AIDS Weekly
Source: AIDS Weekly (2006-06-05)
More Articles from AIDS Weekly
- HIV/AIDS Lipoatrophy
HAART-associated facial lipoatrophy corrected by polylactic acid implants - HIV/AIDS Prognosis
Higher set point HIV-1 RNA and more-severe acute illness predict mortality - HIV/AIDS-Related Kaposi Sarcoma
Kaposi sarcoma remission associated with HIV suppression and is independent of PI therapy - Business Update
Constella Group convenes advisory board led by Tommy G. Thompson - Business Update
Female Health Company receives initial order from Indian government for female condoms - Collaborations
Bristol-Myers Squibb, Gilead submit NDA for Sustiva, Truvada for HIV treatment - More from this issue of AIDS Weekly
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
